Abstract:Gadolinium [Gd(III)]-based polymeric vehicles are gaining attention as potential magnetic resonance imaging (MRI) probes for cancer imaging and diagnosis. In this study, we designed, prepared, and characterized biodegradable block poly[N-(2-hydroxypropyl) methacrylamide] (polyHPMA) copolymer-Gd( III) conjugates through reversible addition-fragmentation chain transfer (RAFT) polymerization, and examined their potential as efficient and biocompatible MRI probes with features that include tunable tumor targeting specificity. An enzyme-sensitive glycylphenylalanylleucylglycine linker (GFLG) was introduced to the backbone of the copolymers, resulting in the formation of a stimuli-responsive linear HPMA copolymer-based agent (pHPMA-DOTA-Gd). The peptide cRGDyK was linked to the copolymer pHPMA-DOTA-Gd, and the resulting copolymer (pHPMA-DOTA-Gd-cRGD) was investigated as a potentially active tumor-targeting MRI contrast agent. The copolymer-Gd(III) conjugates with high molecular weight (MW > 90 kDa) degraded to segments with low MWs (<44 kDa) below the renal threshold. Compared with the clinical agent diethylenediaminepentaacetic acid (DTPA)-Gd, the polymeric conjugates exhibited three-fold more T-1 relaxivity [15.16 mM(-1) s(-1) per gadolinium]. Additionally, gadolinium-based conjugates had greater tumor accumulation in the U87 tumors in mice, and therefore, offered enhanced signal intensity (SI) to MRI. The best in vivo imaging behaviors were mediated by cRGD functionalized conjugates. The 2 polymeric conjugates presented no significant side effects as measured by cytotoxicity, hemocompatibility, and in vivo toxicity studies. Therefore, owing to their great efficacy and good biosafety, the biodegradable block HPMA copolymer-Gd(III) conjugates are promising as targeting MRI probes.

Responsive Gadolinium(iii) Complex-Based Small Molecule Magnetic Resonance Imaging Probes: Design, Mechanism and Application

The role of responsive MRI probes in the past and the future of molecular imaging

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Recent Advances in Gadolinium-Based MRI Metal Responsive Agent

Stimuli-responsive 19F MRI Probes: from Materials Design to in Vitro Detection and in Vivo Diagnosis

Gadolinium-based contrast agents for tumor targeting imaging

Zn2+ Responsive Bimodal Magnetic Resonance Imaging and Fluorescent Imaging Probe Based on a Gadolinium(iii) Complex.

Multifunctional Gadolinium-Based Dendritic Macromolecules As Liver Targeting Imaging Probes.

Supramolecular Design Based Activatable Magnetic Resonance Imaging

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

Artificially Engineered Nanoprobes for Ultrasensitive Magnetic Resonance Imaging.

The properties of Gd 2O 3-assembled silica nanocomposite targeted nanoprobes and their application in MRI

Stimuli-responsive Biodegradable and Gadolinium-Based Poly[n-(2-hydroxypropyl) Methacrylamide] Copolymers: Their Potential As Targeting and Safe Magnetic Resonance Imaging Probes

The Design of Abnormal Microenvironment Responsive MRI Nanoprobe and Its Application

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

High-performance Nanostructured MR Contrast Probes.

Gadolinium-doped Carbon Dots with High Quantum Yield As an Effective Fluorescence and Magnetic Resonance Bimodal Imaging Probe

Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Inorganic Nanoparticle-Based T1 and T1/T2 Magnetic Resonance Contrast Probes.

Gadolinium complexes functionalized persistent luminescent nanoparticles as a multimodal probe for near-infrared luminescence and magnetic resonance imaging in vivo.

Gadolinium-doped Carbon Quantum Dots Loaded Magnetite Nanoparticles As a Bimodal Nanoprobe for Both Fluorescence and Magnetic Resonance Imaging.